A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis

Clinical trial NCT02718300 · TERMINATED

Trial details

NCT number: NCT02718300
Sponsor: Incyte Corporation
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

MPN (Myeloproliferative Neoplasms)

Start date: 2017-02-08
Primary completion: 2021-01-28
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.